Nivolumab effective treatment for malignant mesothelioma

(Singapore–January 30, 2021 11:00 p.m. SPT/January 30, 2021 10:00 a.m. EST)– Nivolumab monotherapy is an effective treatment option for relapsed malignant mesothelioma (MM), according to research presented today at the International Association for the Study of Lung Cancer World Conference on Lung Cancer. Malignant mesothelioma is an intractable cancer, and no phase III trial has…

Details

Selected gene mRNA expression is not predictive of improved overall survival

(Singapore–January 30, 2021 11:00 p.m. SPT/January 30, 2021 10:00 a.m. EST)– A phase III study examining whether messenger (m)RNA expression correlated with sensitivity or resistance to chemotherapy did not confer a statistically significant advantage in overall survival for patients with resected stage II-III non-small cell lung cancer (NSCLC), according to research presented at the International…

Details

LCMC3: Neoadjuvant atezolizumab safe, meets primary endpoint of pathologic response rate

(Singapore–January 30, 2021 11:00 p.m. SPT/January 30, 2021 10:00 a.m. EST)– Primary analysis of the Lung Cancer Mutation Consortium (LCMC) 3 study revealed that neoadjuvant atezolizumab prior to lung cancer surgery was well tolerated by patients and met its primary endpoint of 20% major pathologic response rate, according to research presented today at the International…

Details

ERAS program expedites recovery for congenital heart surgery patients

CHICAGO (January 30, 2021) — Select patients born with heart defects and who undergo congenital heart surgery recover with few complications and reduced opioid use when a comprehensive, evidence-based enhanced recovery after surgery (ERAS) program is used, according to research presented at the 57th Annual Meeting of The Society of Thoracic Surgeons. “We have embarked…

Details

Women undergo less aggressive open heart surgery, experience worse outcomes than men

CHICAGO (January 30, 2021) — Women are significantly less likely than men to undergo coronary artery bypass grafting (CABG) using guideline-recommended approaches, which may result in worse outcomes after surgery, according to a scientific presentation at the 57th Annual Meeting of The Society of Thoracic Surgeons. “This study highlights key differences between women and men…

Details